eBook
The GLP-1 weight loss journey:
How to align data and the consumer experience to maximize ROI
Break down barriers to optimize weight loss before, during and after a GLP-1
There’s no question that GLP-1 medications for obesity work. Backed by a growing body of research, these medications have shown incredible promise in improving health outcomes. However, high drug costs and challenges with adherence often create barriers for employers looking to incorporate GLP-1 coverage into their benefits strategy.
So, how can employers make smart, data-informed decisions in this complex and evolving landscape?
This guide dives deep into the consumer journey of a member taking a GLP-1, uncovering the critical factors that influence adherence, outcomes, and cost-effectiveness.
You’ll gain actionable insights to:
- Understand the challenges and opportunities of GLP-1 coverage.
- Develop strategies to support employee success and adherence.
- Optimize coverage plans to balance costs with impactful outcomes.

Dario is proud to have an 75% retention rate after year one.
Our user-centric approach translates into members who stay engaged with Dario and the healthy behaviors we help them sustain.
Dario's ability to engage people in healthier behaviors that last translates into improved clinical and financial outcomes for our clients.
